Mild Cognitive Impairment (MCI) clinical trials in Pennsylvania
15 active Mild Cognitive Impairment (MCI) trials with a site in Pennsylvania. Describe your situation to see which ones look like a fit.
- A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)
- A Clinical Trial of Trontinemab in Participants With Early Symptomatic Alzheimer's Disease
- Safety And Tolerability Of Gamma Glutamylcysteine (GGC) Oral Supplementation In MCI Patients
- Sense4Safety Intervention
- Evaluating Novel Healthcare Approaches to Nurturing and Caring for Hospitalized Elders
- Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies
- PET Tau - Neurodegenerative Disease Imaging
- Tau PET/CT Imaging in the Mismatch Prospective Cohort Study (MPC-TAU)
- Automated IADL Sensing to Refine Measurement of Older Adult Daily Activity
- Development of a Database to Investigate Digital and Blood-Based Biomarkers and Their Relationship to Tau and Amyloid PET Imaging in Older Participants Who Are Cognitively Normal (CN), Have Mild Cognitive Impairment (MCI), or Have Mild-to-Moderate AD Dementia
- Novel Glaucoma Diagnostics
- Alzheimer's Disease Neuroimaging Initiative 4
- Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)
- A Trial to Evaluate the Safety and Efficacy of Benfotiamine in Patients With Early Alzheimer's Disease (BenfoTeam)
- Longitudinal Early-onset Alzheimer's Disease Study Protocol
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.